Jiangsu Nanfang Medical Tangible Net Worth Ratio
Jiangsu Nanfang Medical tangible net worth ratio. Jiangsu Nanfang Medical (603880) has a Tangible Net Worth Ratio of 75.5% as of June 2026. This metric is calculated by deducting intangible assets (CN¥40.01 Million) from net assets (CN¥163.51 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Jiangsu Nanfang Medical to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Jiangsu Nanfang Medical (2012–2025)
Tangible net worth ratio of Jiangsu Nanfang Medical from 2012 to 2025. This chart shows how Jiangsu Nanfang Medical's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 75.5%, reflecting net assets of CN¥163.51 Million with intangible assets of CN¥40.01 Million CNY. See 603880 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Jiangsu Nanfang Medical Tangible Net Worth Ratio by Year (2012–2025)
Jiangsu Nanfang Medical tangible net worth ratio by year from 2012 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Nanfang Medical from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Jiangsu Nanfang Medical.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.5% | CN¥181.17 Million | CN¥40.78 Million | CN¥927.94 Million | ▼ -7.6 pp |
| 2024 | 85.1% | CN¥284.41 Million | CN¥42.33 Million | CN¥1.06 Billion | ▼ -6.5 pp |
| 2023 | 91.6% | CN¥474.22 Million | CN¥39.64 Million | CN¥1.28 Billion | ▼ -1.9 pp |
| 2022 | 93.5% | CN¥621.48 Million | CN¥40.37 Million | CN¥1.46 Billion | ▼ -1.0 pp |
| 2021 | 94.5% | CN¥654.90 Million | CN¥36.18 Million | CN¥1.24 Billion | ▼ -0.3 pp |
| 2020 | 94.8% | CN¥700.80 Million | CN¥36.71 Million | CN¥1.07 Billion | ▼ -0.4 pp |
| 2019 | 95.2% | CN¥567.52 Million | CN¥27.39 Million | CN¥869.60 Million | ▲ +0.2 pp |
| 2018 | 95.0% | CN¥560.04 Million | CN¥28.09 Million | CN¥845.81 Million | ▲ +4.5 pp |
| 2017 | 90.5% | CN¥537.57 Million | CN¥51.07 Million | CN¥822.96 Million | ▲ +10.8 pp |
| 2016 | 79.7% | CN¥256.69 Million | CN¥52.17 Million | CN¥516.55 Million | ▲ +0.4 pp |
| 2015 | 79.3% | CN¥222.51 Million | CN¥46.08 Million | CN¥473.37 Million | ▼ -5.6 pp |
| 2014 | 84.9% | CN¥210.90 Million | CN¥31.94 Million | CN¥437.01 Million | ▼ -10.2 pp |
| 2013 | 95.0% | CN¥168.57 Million | CN¥8.40 Million | CN¥373.35 Million | ▲ +2.1 pp |
| 2012 | 92.9% | CN¥121.38 Million | CN¥8.61 Million | CN¥379.79 Million | — |